ClinicalTrials.govpublic full text
Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)
renal cell carcinoma, renal cell, melanoma, monoclonal antibodies, phase i, tgf-b, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866047
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.